Pharmaceutical Industry Facing Increasingly Cost-conscious Times According to New Study Into Current and Future Pharma Trends

Business Wire,  April 25, 2008  

• E-mail
• Print
• Link

DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c89912) has announced the addition of Datamonitor's new report: The Pharmaceutical Industry 2008: Current and Future Trends and Strategic Issues Shaping Pharma to their offering.

Today, pharma companies face growing competition from generics and me-too drugs, combined with increasingly tough P&R, a clamp down on healthcare spending, and the need to treat patients for longer due to the aging population. These factors threaten both current and future revenues prompting Pharma to adopt a range of corporate strategies to respond to the changing market dynamics.

Scope

- Review of key external factors impacting Pharma and shaping their strategies

- Analysis of steps undertaken by pharma companies to achieve cost saving and improve efficiency

- Assessment of corporate strategies employed by drug developers to generate new revenue growth

Highlights of this title

Fewer drugs are gaining FDA approval year-on-year, primarily due to increasing pressure the pharmaceutical industry is facing over drug safety, fueled by several recent high-profile drug withdrawals and black box warnings. Compounded with the recent expansion of the FDAs safety powers, this will have a negative impact on Pharmas profitability.

The pharmaceutical industry is facing increasingly cost-conscious times, with a declining ROI and numerous blockbuster products facing imminent generic competition. This is exacerbated by the increasing cost of licensing and M&A deals, and a harshening P&R environment.

A key trend in 2007 has been the vast number of job cuts across Big Pharma in an effort to cut costs, in response to disappointing financial results driven by patent expiries of key products and resulting generic erosion. Price pressure and low reimbursement rates, which are impacting company revenues, are set to continue in 2008.

Key reasons to purchase this title

- Identify the key trends that are impacting the industry in 2007, going forward in 2008 and beyond

- Understand what strategic steps pharma companies are making to maintain their profitability by cutting costs

- Gain insight into how Pharma are capturing new opportunities to sustain historic growth rates

For more information visit http://www.researchandmarkets.com/reports/c89912

Source: Datamonitor

COPYRIGHT 2008 Business Wire
COPYRIGHT 2008 Gale, Cengage Learning